Redox-responsive hyaluronic acid-celastrol prodrug micelles with glycyrrhetinic acid co-delivery for tumor combination therapy
Chinese Chemical Letters · 2025-05 · 36 (5) · 110227
DOI: 10.1016/j.cclet.2024.110227 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Chemical Letters, 2025-05. Verfasst von Li Fu und 5 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sichuan Provincial Science and Technology Support Program.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
- Sichuan Provincial Science and Technology Support Program
Zitieren
APA
Fu, L., Su, Z., Wu, S., Cheng, Y., Hu, C., & Zhang, J. (2025). Redox-responsive hyaluronic acid-celastrol prodrug micelles with glycyrrhetinic acid co-delivery for tumor combination therapy. Chinese Chemical Letters, 36(5), 110227. https://doi.org/10.1016/j.cclet.2024.110227
Vancouver
Fu L, Su Z, Wu S, Cheng Y, Hu C, Zhang J. Redox-responsive hyaluronic acid-celastrol prodrug micelles with glycyrrhetinic acid co-delivery for tumor combination therapy. Chinese Chemical Letters. 2025;36(5):110227. doi:10.1016/j.cclet.2024.110227
BibTeX
@article{Fu2025,
author = {Fu, Li and Su, Ziye and Wu, Shuyang and Cheng, Yanfen and Hu, Chuan and Zhang, Jinming},
title = {Redox-responsive hyaluronic acid-celastrol prodrug micelles with glycyrrhetinic acid co-delivery for tumor combination therapy},
journal = {Chinese Chemical Letters},
year = {2025},
volume = {36},
number = {5},
pages = {110227},
doi = {10.1016/j.cclet.2024.110227}
}
EUVIMED